发明授权
US08404664B2 Phosphonated Rifamycins and uses thereof for the prevention and treatment of bone and joint infections
有权
磷酸化的利福霉素及其用于预防和治疗骨和关节感染的用途
- 专利标题： Phosphonated Rifamycins and uses thereof for the prevention and treatment of bone and joint infections
- 专利标题（中）： 磷酸化的利福霉素及其用于预防和治疗骨和关节感染的用途
-
申请号： US12063300申请日： 2006-08-11
-
公开(公告)号： US08404664B2公开(公告)日： 2013-03-26
- 发明人: Yannick Stephane Rose , Stephane Ciblat , Ting Kang , Adel Rafai Far , Evelyne Dietrich , Yanick Lafontaine , Ranga Reddy
- 申请人： Yannick Stephane Rose , Stephane Ciblat , Ting Kang , Adel Rafai Far , Evelyne Dietrich , Yanick Lafontaine , Ranga Reddy
- 申请人地址： CA St. Laurent, Quebec
- 专利权人： Targanta Therapeutics, Inc.
- 当前专利权人： Targanta Therapeutics, Inc.
- 当前专利权人地址： CA St. Laurent, Quebec
- 代理机构： Roylance, Abrams, Berdo & Goodman, L.L.P.
- 国际申请： PCT/IB2006/004128 WO 20060811
- 国际公布： WO2007/096703 WO 20070830
- 主分类号： A01N57/00
- IPC分类号： A01N57/00 ; A61K31/66 ; C07D225/04
摘要：
The present invention relates to phosphonated Rifamycins, and methods of making and using such compounds. These compounds are useful as antibiotics for prophylaxis and/or the treatment of bone and joint infections, especially for the prophylaxis and/or treatment of osteomyelitis.
公开/授权文献
信息查询
